Study Summary:
A randomized, double-blind, placebo-controlled, relapse prevention study with vilazodone in patients with major depressive disorder.
Qualified Participants Must:
• Be 18 to 70 years of age
•
Have ongoing depressive episode of at least 8 weeks but less than 18 months in duration
Qualified Participants May Receive:
Study medication and study related medical evaluations/diagnstic test at no cost. Reimbursement for time and travel may be provided.